Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06619847 · ClinicalTrials.gov registry record · Phase 2
A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy
A Phase 2 study, sponsored by Vertex Pharmaceuticals Incorporated.
- Completed
- Registry status
- Phase 2
- Development phase
- 367
- Enrollment target
NCT06619847: Completed Phase 2 study, sponsored by Vertex Pharmaceuticals Incorporated.
NCT06619847 is a Phase 2 study that has completed, run by Vertex Pharmaceuticals Incorporated. The registered enrollment target is 367 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (176% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06619847, a Phase 2 study, has completed, sponsored by Vertex Pharmaceuticals Incorporated.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 367 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of VX-993 in treating acute pain after a bunionectomy.
Interventions
- DRUG VX-993
- DRUG Placebo (matched to VX-993)
- DRUG HB/APAP
- DRUG Placebo (matched to HB/APAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 367 participants |
| Start Date | 2024-10-29 |
| Est. Completion | 2025-05-27 |
| Phase | Phase 2 |
What the finished NCT06619847 record still lists
NCT06619847 is an interventional study that assigns participants to a tested intervention. The registered 367 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (176% higher).
The record links to 0 conditions, and to 4 interventions - of which VX-993 is the first listed.
NCT06619847 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06619847 about?
NCT06619847 is a clinical study titled "A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy". The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of VX-993 in treating acute pain after a bunionectomy.
What is the current status of trial NCT06619847?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 367 participants. The study started on 2024-10-29. Estimated completion is 2025-05-27.
What interventions are being tested in trial NCT06619847?
The interventions under investigation include: VX-993 (DRUG), Placebo (matched to VX-993) (DRUG), HB/APAP (DRUG), Placebo (matched to HB/APAP) (DRUG).
Who is sponsoring clinical trial NCT06619847?
This trial is sponsored by Vertex Pharmaceuticals Incorporated, which has 191 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06619847's enrollment target sits among peer trials
367 121st of 2000 higher than 1,880 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI